Company intelligence / Profile preview

Synvia

Paulínia, São Paulo, Brazilsynvia.com ↗

Ownership: Private
Employees: ~750
Development stage: Commercial

Overview

Synvia has conducted thousands of clinical trials across all phases, with extensive experience in bioequivalence studies. It provides high-throughput toxicology testing and central lab services throughout Brazil. No direct therapeutic results since it does not develop its own drugs.

Modalities: Small moleculesGenericsBioequivalence studies
Industry: Contract Research Organization

Beyond the preview

Go deeper on Synvia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synvia.

Explore the full profile